Pluristem Therapeutics Stock Price

-0.0886 (-2.58%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Pluristem Therapeutics Inc PSTI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0886 -2.58% 3.3414 12:26:52
Open Price Low Price High Price Close Price Prev Close
3.38 3.3401 3.44 3.43
Bid Price Ask Price Spread News
3.34 3.35 0.01 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
358 55,810 $ 3.38 $ 188,810 - 3.3199 - 12.15
Last Trade Time Type Quantity Stock Price Currency
12:33:16 30 $ 3.3499 USD


Draw Mode:

Pluristem Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 106.06M 31.74M 22.45M $ 23.00k $ - -1.60 -2.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -955.67k 25.30%

more financials information »

Pluristem Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PSTI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.483.733.31993.53304,034-0.1386-3.98%
1 Month4.104.213.31993.71270,426-0.7586-18.5%
3 Months4.304.553.31993.94380,371-0.9586-22.29%
6 Months7.608.603.31995.24484,910-4.26-56.03%
1 Year8.5112.153.31997.09505,658-5.17-60.74%
3 Years12.6013.802.507.49531,390-9.26-73.48%
5 Years14.8021.202.509.50457,129-11.46-77.42%

Pluristem Therapeutics Description

Pluristem Therapeutics Inc is a US-based company that acts as a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The lead indications are critical limb ischemia, recovery after surgery for femoral neck fracture, and acute radiation syndrome. The company operations are focused on the research, development, clinical trials, and manufacturing of cell therapeutics and related technologies.

Your Recent History
Pluristem ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.